Valproate and HDAC inhibition: a new epigenetic strategy to mitigate phenotypic severity in ALS?
Tremolizzo
L
L
Department of Neuroscience, University of Milano-Bicocca, Monza, Italy.
Rodriguez-Menendez
V
V
Sala
G
G
Di Francesco
J C
JC
Ferrarese
C
C
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000201:enzymology; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D010641:Phenotype; D014635:Valproic Acid / Q000627:therapeutic use*
D056572:Histone Deacetylase Inhibitors; D014635:Valproic Acid